Mitotic percentage index: A new prognostic factor for childhood medulloblastoma

European Journal of Cancer Part A

Volumn 33, Issue 4, 1997, Pages 609-615

  Gilbertson, R J ^a   Jaros, E ^b   Perry, R H ^b   Kelly, P J ^a   Lunec, J ^a   Pearson, A D J ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

c erbB 2; DNA ploidy; medulloblastoma; mitosis; PNET; prognosis

Indexed keywords

GROWTH FACTOR RECEPTOR; ONCOPROTEIN;

ADOLESCENT; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INFANT; MALE; MEDULLOBLASTOMA; MITOSIS; ONCOGENE C ERB; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

ADOLESCENT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; MITOTIC INDEX; PLOIDIES; PROGNOSIS; RECEPTOR, ERBB-2; S PHASE; SURVIVAL ANALYSIS;

EID: 0030968658     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00516-3     Document Type: Article

References (29)

1. Evans AE, Jenkins D, Sposto R, et al. The treatment of medulloblastoma; results of a prospective randomised trial of radiation therapy with and without CCNU vincristine and prednisone. J Neurosurg 1990, 72, 572-582.
2. Bailey CC, Gnewkow A, Welleck S, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the German Society of Paediatric Oncology (GPO), SIOP II. Med Ped Oncol 1995, 25, 166-178.
3. Jenkin D, Goddard K, Armstrong D, et al. Posteria fossa medulloblastoma in childhood. Treatment results and a proposal of a new staging system. Int J Radiat Oncol Biol Phys 1990, 19, 265-274.
4. Zerbini C, Gelber RD, Wienberg D, et al. Prognostic factors in medulloblastoma including DNA ploidy. J Clin Oncol 1990, 11, 616-622.
5. Berry MP, Jenkin RDT, Keen CW. Radiation treatment for medulloblastoma. A 21-year review. J Neurosurg 1981, 55, 43-51.
6. Halberg FA, Wara WM, Fippin N. Low dose craniospinal radiation therapy for medulloblastoma. Int J Radiat Oncol Biol Phys 1991, 20, 651-654.
7. Kun LE, Constine LS. Medulloblastoma; caution regarding new treatment approaches. Int J Biol Radiat Phys 1991, 20, 897-899.
8. Packer RJ, Sutton LN, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994, 81, 690-698.
9. Allen JC, Epstein F. Medulloblastoma and other malignant neuroectoderaml tumours of the CNS. The effect of patient age and extent of disease upon prognosis. J Neurosurg 1982, 57, 446-451.
10. Kopleson G, Lingood RM, Klienman GM. Medulloblastoma. The identification of prognostic subgroups and implications for multimodality treatment. Cancer 1983, 51, 312-319.
11. Caputy AJ, McCullough DC, Herbert MJ, Patterson K, Hammock MK. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation. J Neurosurg 1987, 66, 80-87.
12. Haapasalo H, Collan Y, Atkin NB, Pesonen E, Seppa A. Prognosis ovarian carcinomas: prediction by histoquantitative methods. Histopathology 1989, 15, 167-170.
13. Lipponen PK, Eskelinen MJ, Collan Y, Marin S, Alhava E. Volume-corrected mitotic index in pancreatic cancer. Scand J Gastroenterol 1990, 25, 548-552.
14. Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho R, Haapasalo H. Grading of superficial bladder cancer by quantitative mitotic frequency analysis. J Urol 1993, 149, 36-41.
15. Merkel DE, Dresseler LG, McGuire WL. Flow cytometry, cellular DNA content and prognosis in human malignancy. J Clin Oncol 1987, 5, 1609-1703.
16. Stavale JN, Cruz JR. Desmoplastic medulloblastoma: histological factors of prognosis. Arquivos de Neuro-Psiquitra 1993, 51, 487-490.
17. Ellis PSJ, Whitehead R. Mitoses counting - a need for reappraisal. Hum Pathol 1981, 12, 3-4.
18. Baak JPA. Mitosis counting in tumours. Hum Pathol 1990, 21, 683-684.
19. Quinn CM, Wright NA. The value of mitotic counting in the assessment of prognosis and proliferation in human tumours. Authors' reply. J Pathol 1990, 163, 362.
20. Aherne WA, Al-Wiswazy M, Ford D, Kellermen M. Assessment of inherent fluctuations of mitotic and labelling indices of human tumours. Br J Cancer 1977, 36, 577-591.
21. Yasue M, Tomita T, Engelhard H. Prognostic importance of DNA ploidy in medulloblastoma of childhood. Cancer 1989, 70, 385-391.
22. Schofield DE, Yunis EJ, Geyer JR, Albright AL, Berger MS, Taylor SR. DNA content and other prognostic features in childhood medulloblastoma. Cancer 1992, 69, 1307-1314.
23. Tait DM, Eeles RA, Cater R, Ashley S, Ormerod MG. Ploidy and proliferative index in medulloblastoma: useful prognostic factors? Eur J Cancer 1993, 29A, 1383-1387.
24. Niggili FK, Powell JE, Parkes SE. DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators. Br J Cancer 1994, 69, 1106-1110.
25. Gilbertson RJ, Jaros E, Perry RH, Kelly P, Pearson ADJ. Prognostic significance of the c-erb B2 oncogene product in childhood medulloblastoma. Br J Cancer 1995, 71, 473-477.
26. Lashford LS, Campbell RHA, Gattamaneni HR, Robinson K, Walker D, Bailey C. An intensive multiagent chemotherapy regimen for brain tumours occuring in very young children. Arch Dis Child 1996, 74, 215-223.
27. Chang CH, Housepain EM, Herbert C. An operative staging system and a megavoltage therapeutic technique for cerebellar medulloblastoma. Radiology 1969, 93, 1352-1359.
28. Hedley DW, Friedlander Ml, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983, 31, 1333-1335.
29. Scott N, Cross D, Plumb MI, Dixon MF, Quirke P. An investigation of different methods of cell cycle analysis by flow cytometry in rectal cancer. Br J Cancer 1992, 65, 8-10.